BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14684381)

  • 1. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice.
    Tashiro M; Samuelson LC; Liddle RA; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G784-90. PubMed ID: 14684381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin-dependent and calcineurin-independent signal transduction pathways activated as part of pancreatic growth.
    Tashiro M; Dabrowski A; Guo L; Sans MD; Williams JA
    Pancreas; 2006 Apr; 32(3):314-20. PubMed ID: 16628088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
    Jia D; Taguchi M; Otsuki M
    Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of early response genes in trypsin inhibitor-induced pancreatic growth.
    Guo L; Sans MD; Gurda GT; Lee SH; Ernst SA; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G667-77. PubMed ID: 17095753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
    Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulator of calcineurin 1 controls growth plasticity of adult pancreas.
    Gurda GT; Crozier SJ; Ji B; Ernst SA; Logsdon CD; Rothermel BA; Williams JA
    Gastroenterology; 2010 Aug; 139(2):609-19, 619.e1-6. PubMed ID: 20438729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice.
    Crozier SJ; Sans MD; Guo L; D'Alecy LG; Williams JA
    J Physiol; 2006 Jun; 573(Pt 3):775-86. PubMed ID: 16613881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice.
    Crozier SJ; Sans MD; Lang CH; D'Alecy LG; Ernst SA; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1148-57. PubMed ID: 18356533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain.
    Luo J; Ma J; Yu DY; Bu F; Zhang W; Tu LH; Wei Q
    Brain Res Bull; 2008 Jul; 76(5):464-8. PubMed ID: 18534252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
    Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
    Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
    Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
    Merten KE; Jiang Y; Feng W; Kang YJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hypergastrinemia and blockade of gastrin-receptors on pancreatic growth in the mouse.
    Niederau C; Niederau M; Klonowski H; Lüthen R; Ferrell LD
    Hepatogastroenterology; 1995; 42(4):423-31. PubMed ID: 8586382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precocious alteration of digestive enzyme activities in small intestine and pancreas by chronic oral administration of protease inhibitor in suckling rats.
    Harada E; Syuto B
    Comp Biochem Physiol A Comp Physiol; 1991; 100(2):467-72. PubMed ID: 1685962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice.
    Sato N; Suzuki S; Kanai S; Ohta M; Jimi A; Noda T; Takiguchi S; Funakoshi A; Miyasaka K
    Jpn J Pharmacol; 2002 Jul; 89(3):290-5. PubMed ID: 12184735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.
    Gurda GT; Guo L; Lee SH; Molkentin JD; Williams JA
    Mol Biol Cell; 2008 Jan; 19(1):198-206. PubMed ID: 17978097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval.
    Lateef DM; Washington MC; Sayegh AI
    Peptides; 2011 Jun; 32(6):1289-95. PubMed ID: 21453733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal control of pancreatic growth.
    Mainz DL; Black O; Webster PD
    J Clin Invest; 1973 Sep; 52(9):2300-4. PubMed ID: 4727460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8.
    Yamamoto M; Reeve JR; Keire DA; Green GM
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G866-79. PubMed ID: 15550556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.